Potential of Raloxifene in reversing osteoarthritis-like alterations in rat chondrocytes: An in vitro model study

Journal of Biosciences

Volumn 38, Issue 1, 2013, Pages 135-147

  Kavas, Aysegul ^a   Cagatay, Seda Tuncay ^a   Banerjee, Sreeparna ^a   Keskin, Dilek ^a,b   Tezcaner, Aysen ^a,b  

^a Technical University   (Turkey)

^b MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Agarose; cartilage; chondroprotective; in vitro models; osteoarthritis; Raloxifene

Indexed keywords

AGGRECAN; ALKALINE PHOSPHATASE; CASPASE 3; COLLAGEN TYPE 10; COLLAGEN TYPE 2; COLLAGENASE 3; GELATINASE A; MESSENGER RNA; RALOXIFENE; STROMELYSIN;

BONE; CHEMICAL COMPOUND; GENE EXPRESSION; OSTEOLOGY; RODENT; SKELETON;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARTILAGE CELL; CHONDROPROTECTION; COLLAGEN DEGRADATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; GENE EXPRESSION; IN VITRO STUDY; NONHUMAN; OSTEOARTHRITIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

RATTUS;

EID: 84873706380     PISSN: 02505991     EISSN: 09737138     Source Type: Journal    
DOI: 10.1007/s12038-012-9282-7     Document Type: Article

References (53)

1. Aigner T, Zien A, Gehrsitz A, Gebhard PM and McKenna L 2001 Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum. 44 2777-2789
2. Badurski JE, Daniluk S, Dobrenko A, Nowak NA, Jeziernicka EZ and Holiczer W 2005 A significant improvement of womac and lequesne indexes after treatment with raloxifene in women with knee osteoarthritis [abstract]. Osteoarthritis Cartilage 13 (Suppl 1) S82
3. Bastiaansen-Jenniskens YM, Koevoet W, de Bart AC, van der Linden JC, Zuurmond AM, Weinans H, Verhaar JA, van Osch GJ, et al. 2008 Contribution of collagen network features to functional properties of engineered cartilage. Osteoarthritis Cartilage 16 359-366
4. Bellosta S, Baetta R, Canavesi R, Comparato C, Granata A, Monetti M, Cairoli F, Eberini I, et al. 2007 Raloxifene inhibits matrix metalloproteinases expression and activity in macrophages and smooth muscle cells. Pharmacol. Res. 56 160-167
5. Benya PD and Shaffer JD 1982 Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell 30 215-224
6. Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, Mitchell P, Hambor J, et al. 1997 Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J. Clin. Invest. 99 1534-1545
7. Blanco FJ, Guitian R, Vazquez-Martul E, de Toro FJ and Galdo F 1998 Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis pathology. Arthritis Rheum. 41 284-289
8. Bolognese MA 2010 SERMs and SERMs with estrogen for postmenopausal osteoporosis. Rev. Endocr. Metab. Disord. 11 253-259
9. Bonassar LJ, Grodzinsky AJ, Frank EH, Davila SG, Bhaktav NR and Trippel SB 2001 The effect of dynamic compression on the response of articular cartilage to insulin-like growth factor-I. J. Orthop. Res. 19 11-17
10. Cawston TE and Young DA 2010 Proteinases involved in matrix turnover during cartilage and bone breakdown. Cell Tissue Res. 339 221-235
11. Christodoulakos GE, Panoulis CP, Lambrinoudaki IV, Botsis DS, Dendrinos SG, Economou E and Creatsas GC 2004 The effect of hormone therapy and raloxifene on serum matrix metalloproteinase-2 and -9 in postmenopausal women. Menopause 11 299-305
12. Dadiboyena S 2012 Recent advances in the synthesis of raloxifene: a selective estrogen receptor modulator. Eur. J. Med. Chem. 51 17-34
13. De Croos JNA, Dhaliwal SS, Grynpas MD, Pilliar RM and Kandel RA 2006 Cyclic compressive mechanical stimulation induces sequential catabolic and anabolic gene changes in chondrocytes resulting in increased extracellular matrix accumulation. Matrix Biol. 25 323-331
14. Deshmukh K and Nimni ME 1973 Isolation and characterization of cyanogen bromide peptides from the collagen of bovine articular cartilage. Biochem. J. 133 615-622
15. Eid K, Thornhill TS and Glowacki J 2006 Chondrocyte gene expression in osteoarthritis: correlation with disease severity. J. Orthop. Res. 24 1062-1068
16. Farndale RW, Buttle DJ and Barrett AJ 1986 Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim. Biophys. Acta 883 173-177
17. Gannon JM, Walker G, Fischer M, Carpenter R, Thompson RC and Oegema TR 1991 Localization of type X collagen in canine growth plate and adult canine articular cartilage. J. Orthop. Res. 9 485-494
18. Guiducci S, Del Rosso A, Cinelli M, Perfetto F, Livi R, Rossi A, Gabrielli A, Giacomelli R, et al. 2005 Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis. Arthritis Res. Ther. 7 R1244-R1253
19. Hansen U, Schünke M, Domm C, Ioannidis N, Hassenpflug J, Gehrke T and Kurz B 2001 Combination of reduced oxygen tension and intermittent hydrostatic pressure: a useful tool in articular cartilage tissue engineering. J. Biomech. 34 941-949
20. Hashimoto S, Ochs RL, Komiya S and Lotz M 1998 Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis. Arthritis Rheum. 41 1632-1638
21. Hattori Y, Kojima T, Kato D, Matsubara H, Takigawa M and Ishiguro N 2012 A selective estrogen receptor modulator inhibits tumor necrosis factor-α-induced apoptosis through the ERK1/2 signaling pathway in human chondrocytes. Biochem. Biophys. Res. Commun. 421 418-424
22. Hidvegi NC, Sales KM, Izadi D, Ong J, Kellam P, Eastwood D and Butler PE 2006 A low temperature method of isolating normal human articular chondrocytes. Osteoarthritis Cartilage 14 89-93
23. Ho ML, Chang JK, Wu SC, Chung YH, Chen CH, Hung SH and Wang GJ 2006 A novel terminal differentiation model of human articular chondrocytes in three dimensional cultures mimicking chondrocytic changes in osteoarthritis. Cell Biol. Int. 30 288-294
24. Hoemann CD, Sun J, Chrzanowski V and Buschmann MD 2002 A multivalent assay to detect glycosaminoglycan, protein, collagen, RNA, and DNA content in milligram samples of cartilage or hydrogel-based repair cartilage. Anal. Biochem. 300 1-10
25. Jiang T, Petersen RR, Call G, Ofek G, Gao J and Yao JQ 2011 Development of chondroitin sulfate encapsulated PLGA microsphere delivery systems with controllable multiple burst releases for treating osteoarthritis. J. Biomed. Mater. Res. B Appl. Biomater. 97 355-363
26. Jochems C, Islander U, Kallkopf A, Lagerquist M, Ohlsson C and Carlsten H 2007 Role of raloxifene as a potent inhibitor of experimental postmenopausal polyarthritis and osteoporosis. Arthritis Rheum. 56 3261-3270
27. Kavas A, Ozdemir M, Gürses S, Keskin D and Tezcaner A 2011 In vitro investigation and biomechanical modeling of the effects of PLF-68 on osteoarthritis in a three-dimensional model. Biomech. Model. Mechanobiol. 10 641-650
28. Kirsch T, Swoboda B and Nah H 2000 Activation of annexin II and V expression, terminal differentiation, mineralization and apoptosis in human osteoarthritic cartilage. Osteoarthritis Cartilage 8 294-302
29. Lorenz H and Richter W 2006 Osteoarthritis: Cellular and molecular changes in degenerating cartilage. Prog. Histochem. Cytochem. 40 135-163
30. Lu T, Achari Y, Sciore P and Hart DA 2006 Estrogen receptor alpha regulates matrix metalloproteinase-13 promoter activity primarily through the AP-1 transcriptional regulatory site. Biochim. Biophys. Acta 1762 719-731
31. Malemud CJ, Islam N and Haqqi TM 2003 Pathophysiological mechanisms in osteoarthritis lead to novel therapeutic strategies. Cell. Tiss. Org. 174 34-48
32. Mauck RL, Seyhan SL, Ateshian GA and Hung CT 2002 Influence of seeding density and dynamic deformational loading on the developing structure/function relationships of chondrocyte-seeded agarose hydrogels. Ann. Biomed. Eng. 30 1046-1056
33. Mauck RL, Soltz MA, Wang CCB, Wong DD, Chao PHGC, Valhmu WB, Hung CT and Ateshian GA 2000 Functional tissue engineering of articular cartilage through dynamic loading of chondrocyte-seeded agarose gels. J. Biomech. Eng. 122 252-260
34. Na K, Park JH, Sun BK, Woo DG, Chung HM and Park KH 2006 Delivery of dexamethasone, ascorbate, and growth factor (TGF beta-3) in thermo-reversible hydrogel constructs embedded with rabbit chondrocytes. Biomaterials 27 5951-5957
35. Nesic D, Whiteside R, Brittberg M, Wendt D, Martin I and Mainil-Varlet P 2006 Cartilage tissue engineering for degenerative joint disease. Adv. Drug Deliv. Rev. 58 300-322
36. O'Hara BP, Urban JP and Maroudas A 1990 Influence of cyclic loading on the nutrition of articular cartilage. Ann. Rheum. Dis. 49 536-539
37. Poole AR 2003 What type of cartilage repair are we attempting to attain? J. Bone Joint Surg. Am. 85-A Suppl 2 40-44
38. Rees JA and Ali SY 1988 Ultrastructural localisation of alkaline phosphatase activity in osteoarthritic human articular cartilage. Ann. Rheum. Dis. 47 747-753
39. Richy F, Bruyere O, Elthgen O, Cucherat M, Henrotin Y and Reginster JY 2003 Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch. Intern. Med. 163 1514-1522
40. Roman-Blas JA, Castañeda S, Largo R, Herrero-Beaumont G 2009 Osteoarthritis associated with estrogen deficiency. Arthritis Res. Ther. 11 241
41. Saito S, Katoh M, Masumoto M, Matsumoto S and Macho Y 1998 Involvement of MMP-1 and MMP-3 in collagen degradation induced by IL-1 in rabbit cartilage explants culture. Life Sci. 62 359-365
42. Sandell LJ and Aigner T 2001 Articular cartilage and changes in arthritis. An introduction: Cell biology of osteoarthritis. Arthritis Res. 3 107-113
43. Sang QA, Bodden MK and Windson LJ 1996 Activation of human progelatinase A by collagenase and matrilysin: activation of procollagenase by matrilysin. J. Protein Chem. 15 243-253
44. Sharma G, Saxena RK and Mishra P 2007 Differential effects of cyclic and static pressure on biochemical and morphological properties of chondrocytes from articular cartilage. Clin. Biomech. 22 248-255
45. Snikers YH, Weinans H, Bierma-Zeinstra SM, van Leuwen JP, van Osch GJ 2008 Animal models for osteoarthritis: the effect of ovariectomy and estrogen treatment- a systematic approach. Osteoarthritis Cartilage 16 533-541
46. Sumantran VN, Kulkarni A, Boddul S, Chinchwade T, Koppikar SJ, Harsulkar A, Patwardhan B, Chopra A, et al. 2007 Chondroprotective potential of root extracts of Withania somnifera in osteoarthritis. J. Biosci. 32 299-307
47. Tinti L, Niccolini S, Lamboglia A, Pascarelli NA, Cervone R and Fioravanti A 2011 Raloxifene protects cultured human chondrocytes from IL-1beta induced damage: a biochemical and morphological study. Eur. J. Pharmacol. 670 67-73
48. Toyoda T, Seedhom BB, Yao JQ, Kirkham J, Brookes S and Bonass WA 2003 Hydrostatic pressure modulates proteoglycan metabolism in chondrocytes seeded in agarose. Arthritis Rheum. 48 2865-2872
49. van der Eerden BC, Gevers EF, Lövik CW, Karperien M and Wit JM 2002 Expression of estrogen receptor alpha and beta in the epiphyseal plate of the rat. Bone 30 478-485
50. Williamson AK, Chen AC and Sah RL 2001 Compressive properties and function composition relationships of developing bovine articular cartilage. J. Orthop. Res. 19 1113-1121
51. Wołczynski S, Surazyński A, Swiatecka J and Pałka J 2001 Estrogenic and antiestrogenic effects of raloxifene on collagen metabolism in breast cancer MCF-7 cells. Gynecol. Endocrinol. 15 225-233
52. Wu JJ, Lark MW, Chun LE and Eyre DR 1991 Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage. J. Biol. Chem. 266 5625-5628
53. Zbucka M, Miltyk W, Bielawski T, Surazynski A, Palka J and Wolczynski S 2007 Mechanism of collagen biosynthesis up-regulation in cultured leiomyoma cells. Folia Histochem. Cytobiol. 45 (Suppl 1) S181-S185